ADAMA Ltd. (the “Company”) (SZSE: 000553), today reported its financial resultsfor the third quarter and first nine months of 2025 that ended September30, 2025.
https://mma.prnewswire.com/media/799829/Adama_Agricultural_Solutions_Logo.jpg
Third Quarter 2025Highlights:
— StableSales(0% in USD, 1% in RMB)of$933million, reflecting the combined results of a 1% increase in volume and a1% decrease in prices
— Adjusted gross profitup 14% to $257 million, representing an improvement of gross margin to 27.6% from 24.2% last year, reflecting the benefits of lower costs and higher volumes
— Adjusted EBITDAup 50% to $120 million, representing an improvement of EBITDA margin to 12.9% from 8.6% last year
— Adjusted netlossreduced to$20million from$78million last year; Reportednet lossimproved by $85 million to $48million compared to $133million last year
First Nine Months 2025 Highlights:
— Stable Sales(0% in USD, 1% in RMB)of $3,025million, reflecting the combined results of a 3%increase in volume and a 3% decrease in prices
— Adjusted gross profitup 12% to $878million, representing an improvement of gross margin to 29.0% from 25.8% last year, reflecting the benefits of lower costs and higher volumes
— Adjusted EBITDAup 30% to $430million, representing an improvement of EBITDA margin to 14.2% from 11.0% last year
— Adjusted net incometurned positive to $29million compared toa loss of $149million last year; Reportednet lossimproved by $200 million to $59million compared to $259million last year
— Operating cash flowof $331million generated vs.$402million last year
— Free cash flowof $112 million vs. $179million last year
Gaël Hili, President and CEO of ADAMA, said, “In the third quarter, we continued to deliver improved financial results with stable sales and our sixth consecutive quarter of year-over-year EBITDA growth, clear indicators that our Fight Forward transformation plan is delivering results in support of our value innovation strategy. We remain focused on strengthening our operational foundations, enhancing commercial execution, and driving innovation across our portfolio, delivering meaningful impact for farmers and positioning ADAMA for sustainable, long-term profitable growth.”
Table 1. Financial Performance Summary
Notes:
“As Reported” denotes the Company's financial statements according to the Accounting Standards for Business Enterprises and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the ChineseMinistryof Finance (the “MoF) (collectively referred to as “ASBE”). Note that in the reported financial statements, according to the ASBE guidelines [IAS 37], certain items (specifically certain transportation costs and certain idleness charges) are classified under COGS. Please see the appendix to this release for further information.
Relevant income statement items contained in this release are also presented on an “Adjusted” basis, which exclude items that are of a transitory or non-cash/non-operational nature that do not impact the ongoing performance of the business and reflect the way the Company's management and the Board of Directors view the performance of the Company internally. The Company believes that excluding the effects of these items from its operating results allows management and investors to effectively compare the true underlying financial performance of its business from period to period and against its global peers. A detailed summary of these adjustments appears in the appendix below.
The number of shares used to calculate both basic and diluted earnings per share in both Q3 and 9M 2025 and 2024is 2,329.8 million shares.
In this table and all tables in this release numbers may not sum due to rounding.
The General Crop Protection (CP) Market Environment
Through the first nine months of 2025, channel inventory returned to pre-pandemic levels in most countries, allowing crop protection demand recovery. Pricing pressure remains high, driven by production over-capacity of active ingredients. Crop commodity prices remain stably low and coupled with the high-interest rate environment, farmer profitability remains tight leading to just-in-time purchasing patterns.[1]
Portfolio Development Update
In the third quarter 2025, ADAMA continued to register and launch multiple new products in markets across the globe, adding on to its differentiated product portfolio. As part of the Fight Forwardtransformation plan, the Company is focused on improving its overall portfolio mix, particularly by targeting the Value Innovation segment, with the intent of improving value delivered to all stakeholders.
In Q3 2025,launchesof differentiated products included:
— FERRABAIT®, a patented molluscicide composition based on the active ingredient FERALLA®, has been launched in New Zealand for use in arable, horticultural, and ornamental crops.
— COSAYR®,a long-lasting Chlorantraniliprole-based suspension, has been launched in Canada, Hungary, and Argentina (as CARTADO®), to deliver fast and effective control of chewing insects across a wide range of horticultural and field crops.
Notable differentiated product registrations during Q3 2025 included:
— PORAFAM®, an herbicide aqueous solution with Aminopyralid as the active ingredient, has been registered in Germany. This marks ADAMA's first registration of an Aminopyralid-based formulation in Europe.
— The active substance FERALLA® was registered UK
— COSAYR® was registered inAustria, France, Spain and Greece
— AVASTEL®a broad-spectrum fungicide utilizing Asorbital Formulation Technology and combining the active ingredients Prothioconazole and Fluxapyroxad, has been officially registered in Germany.
— EDAPTIS®has been registered in Germany. This innovative post-emergence herbicide combines Pinoxaden and Mesosulfuron-methyl to provide effective control of a broad spectrum of grasses, including resistant populations, with a patented formulation that ensures stable and reliable performance.
— REXARO® a fungicide suspension containing Cymoxanil and Fluopicolide, has been registered in Ghana.
— ETHOSAT®,an herbicide suspension based on Ethofumesate active ingredient, has been registered in Finland.
In addition,patentsgranted during Q3 2025 included GILBOA® mixtures patents in multiple countries including Europe and US, and Gilboa formulation patents in the US and Columbia. Gilboa is a proprietary fungicide having a new mode of action for use in cereals. As well, BAROZ™,a unique granular formulation for reliable rice stem borer control, waspatented in Colombia and Indonesia.
Geopolitical Situation
ADAMA is headquartered and has three manufacturing sites in Israel. The regional tensions which escalated on October 7, 2023, continuedto have no material impact to-date on the Company's ability to support its markets or its consolidated financial results.
ADAMA is a global company with manufacturing and formulation facilities in severallocations around the world, principally in Israel, China and Brazil. The Company's management appointed a dedicated task force to analyze implications of US tariff policies and to closely monitor and manage the situation and the potential impact on its global network. Despite the uncertainty regarding the US tariff policies, the Company currently expects that the impact on its operations and business results will be immaterial.
'Fight Forward' Transformation Plan
In early 2024, ADAMA launched 'Fight Forward', a strategic transformation plan designed to deliver improved profit and cash targets over a three-year period. The plan optimizes financial management, streamlining ADAMA's operating model in order to increase focus on the Value Innovation segment in which differentiated, high-impact solutions are developed to deliver greater value to farmers.
Financial Highlights
Revenues in the third quarter were stable (1% in RMB; 0%in CER) reaching$933million, mainly reflectingthe combined results of a1% increase in volumeand a1% decrease in prices. The higher volumesreflectedthe gradual recovery of market demands and improvement of channel inventories in most regions. Prices remained weak mainly due to low prices of active ingredients in light of overcapacity, as well as a high interest rate environment and low commodity prices, which put pressure on distributors and farmers.
Revenues in the first nine months were also stable (1% in RMB; 1% in CER) reaching $3,025 million. The stabilization of revenues in the first nine months was driven by volume growth of 3% offsetting a decrease in prices of 3%.
Table 2. Regional Sales Performance
Notes:
‒ CER: Constant Exchange Rates
‒ As part of ADAMA's business optimization program, on January 1, 2025, ADAMA's South Africa business was reclassified from APAC operations to EAME operations. To enable meaningful comparisons, the 2024 data presented here includes South Africa under EAME.
‒ Numbers may not sum due to rounding
Europe, Africa & Middle East (EAME): Volumes and revenue in EAME increased in the third quarter, though significant Q1 declines in Turkey impacted the year-to-date results. Pricing continued to decline in light of intense competition. Foreign exchange rates had positive impact in the third quarter.
North America:In the US Ag market, though slightly down in the third quarter, was significantly up in the first nine months following improvements in volumes and prices. Similarly in Canada, while the third quarterwas flat with an increase in volume offset by a decrease by prices, for the nine months volumes are significantly up. Consumer & Professional Solutions experienced increased volumes and flat prices for both the third quarter and year-to-date.
Latin America: In Brazil, revenues were significantly up in the third quarter, resulting in higher revenues also for the first nine monthscompared to the previous year. Growth was driven by increased volumes, while the third quarter also experienced modest pricing increases. In the rest of LATAM lower volumes, prices, and revenues were reported in the third quarter and the first nine months, primarily in Paraguay and Argentina, due to channel destocking and just-in-time purchasing behavior.
Asia-Pacific (APAC):India experienced significant declines in the third quarter revenues, primarily due to lower volumes driven by extreme weather conditions and lower prices. In the rest of APAC (excluding India and China), sales and volumes were slightly up for the quarter, despite ongoing pricing pressures.
In China, sales in the third quarter mainly reflected the impacts of lower non-ag sales, partially compensated by the increase of AI sales. Non-ag sales declined following implementation of the company's strategic decision to pivot away from manufacturing some basic chemical products, and weaker market demands. Higher AI sales weredriven by volume growth due to the expansion of new distribution channels and supported by the recovery of global demand. Sales of the formulations business stabilized, still reflecting relatively high channel inventories and severe market competition. Supported by the growth in the first half, sales in China in the first nine months increased compared to last year.
Reported gross profitin the third quarter increased 25% to $236 million (gross margin of 25.2%) from$188 million (gross margin of20.2%) last year, and increased 18% to$792 million (gross margin of 26.2%) in the first nine monthsfrom$672 million (gross margin of 22.2%) last year.
Adjustments to reported results: The adjusted gross profit mainly includes reclassification of inventory impairment, taxes and surcharge, and excludes certain transportation costs (classified under operating expenses)and the remediation costs by a wholly owned subsidiary for its plant in Israel.
Adjustedgross profit in the third quarter increased14% to $257 million (gross margin of 27.6%) from $225million (gross margin of 24.2%) last year, and increased 12% to$878million (gross margin of 29.0%) in the first nine monthsfrom$782 million (gross margin of 25.8%) last year.
The higher adjusted gross profit and margin in the quarter and first nine months mainly reflected the positive impacts of lower costs due to improved operational efficiency and lower costs of inventory soldas well as higher volume, more than compensating for lower prices.
Operating expensesreported in the third quarter were$205million (22.0% of sales), compared to $222million (23.9% of sales) last year, and were $636million (21.0% of sales) in the first nine monthscompared to $671million (22.2% of sales) last year.
Adjustments to reported results: Please refer to the explanation above regarding adjustments to the gross profit in respect to certain transportation costs, taxes and surcharges and inventory impairment. Non-operating income and expenses are also reclassified into adjusted operating expenses.
The Company recorded certain non-operational items within its reported operating expenses amounting to $26 million in the third quarter of2025in comparison to $37million in the third quarter of 2024 and$73 million in the first nine months 2025 in comparison to $113million in the first nine months 2024. These items in 2025 mainly include: i.non-cash amortization charges in respect of transfer assets received from Syngenta related to the 2017 ChemChina-Syngenta acquisition;ii.non-cash amortization net charges related to intangible assets created as part of the Purchase Price Allocation (PPA) on acquisitions;and iii. restructuring and advisory costs incurred as part of the implementation of the Fight Forward transformation plan. For further details on these non-operational items, please see the appendix to this release.
Adjustedoperating expenses in the third quarter were $201million (21.5%of sales), compared to $212 million (22.8% of sales) last year, and were $641million (21.2% of sales) in the first nine monthscompared to $645million (21.3% of sales) last year.
The lower operating expenses in the third quarter was mainly due to a credit loss recordedlast year, which compensated for an increase in expenses attributed to company success-based employee compensation due to improved 2025 results to-date. For the first nine months, the positive impacts following implementation of the Fight Forward plan more than compensated for expected credit lossesdue to liquidity issues of some local distributors in certain countries.
Reported operating income in the third quarter was$30million (3.2% of sales) compared toa loss of $34million (-3.6% of sales) last year, and increasedto $155 million (5.1% of sales) in the first nine months from$1 million (0.0% of sales) last year.
Adjustedoperating income in the third quarter increased to $56million (6.0% of sales) from $13million (1.4%of sales) last year, and increased to $237million (7.8% of sales) in the first nine monthsfrom$137million (4.5% of sales) last year. The increase in operating income was a combined result of higher gross profit and lower operating expenses.
Reported EBITDAin the third quarter increased to $104million (11.2% of sales) from $56million (6.0% of sales) last year, and increased to $378 million (12.5% of sales) in the first nine months from$252million (8.3% of sales) last year.
AdjustedEBITDA in the third quarter increased to $120million (12.9% of sales) from $80million (8.6% of sales) last year, and increased to $430million (14.2% of sales) in the first nine months from$332million (11.0% of sales) last year.
Adjusted financial expenses decreased to $68 million in the third quarter compared to $84million last year, and decreased to $204million in the first nine months compared to $224million last year.
The lower financial expenses inboth the third quarter and the first nine months were primarily positively impacted by a bond buyback that was executed in late Q2, as well as the lower hedging costs related to the Israeli Shekel.
Adjusted taxes on incomein the third quarter were an expense of $8 million, compared to expenses of $6 million in the corresponding period last year, and amounted to an expense of $4 million in the first nine months compared to expenses of $61 million last year.
The Company recorded tax expenses mainly because losses that were primarily incurred by subsidiaries with relatively lower tax rates, while some of them did not create deferred tax assets on the losses. On the other hand, the subsidiaries that generated profit have a higher tax rate.
The tax expenses in first nine months of 2025 are lower compared to the first nine months of 2024 due to (1) lower losses in subsidiaries that did not create deferred tax assets; (2) tax income raised by the accounting method of calculation of tax assets related to unrealized profits; and (3) foreign exchange impact of the stronger BRL in 2025 compared with tax expenses due to the weakness of the BRL in the first nine month of 2024.
Net loss reported in the third quarter narrowed to $48 million from$133million last year, and narrowed to $59 millionin the first nine months from$259 millionlast year.
After reflecting the impact of the aforementioned extraordinary and non-operational charges, adjusted net lossin the third quarter was reduced to $20millionfroma loss of $78million last year, and adjusted net income in the first nine months turned positive to $29million from a loss of$149 millionlast year.
Trade working capitalas of September 30, 2025, was $2,093million compared to $2,218 million as of September 30, 2024. The decrease in working capital was mainly due to the decline in the level of inventoryto $1,685million as of September30, 2025, from$1,740million as of September 30, 2024. The decline of inventories was a result of continued implementation of enhanced inventory management, more than offsetting increased procurement in preparation to capture momentum as the market recovers, which also led to an increase in trade payables.
Cash Flow: Operating cash flow of $89million and $331million was generated in the third quarter and First Nine Months respectively, compared to $159million and $402million generated in the correspondingperiodslast year. The lower operating cash flowgenerated in the third quarter was mainly due to higher procurement payments in preparation to capture growth momentum. The dynamics in the first nine months reflected an improvement in collection offsetting higher outflow due to increased procurement payments.
Net cash used in investing activities was $43million in the third quarter and $131million in the First Nine Months, compared to $7 million and $122million in the corresponding periods last year, respectively. The highercash used in investing activities in the third quarter was mainly due to inflow from last year's sale of a real estate asset. For the first nine months, the mild increase was also due to the payment for earn out related to AgriNova, a controlled subsidiary of the Company in Q2, more than offsetting prioritization of investments in manufacturing facilities and portfolio optimization.
Free cash flow of $22 million was generated in the third quarter and $112million generated in the First Nine Months compared to $128million and $179million in the corresponding periods last year, respectively, reflecting the aforementioned operating and investing cash flow dynamics.
Table 3. Revenues by operating segment
Sales by segment
Sales by product category
Notes:
The sales split by product category is provided for convenience purposes only and is not representative of the way the Company is managed or in which it makes its operational decisions.
Numbers may not sum due to rounding.
Further Information
All filings of the Company, together with a presentation of the key financial highlights of the period, can be accessed through the Company website at www.adama.com.
About ADAMA
ADAMA Ltd. is a global leader in crop protection, providing practical solutions to farmers across the world to combat weeds, insects and disease. Our culture empowers ADAMA's people to actively listen to farmers and ideate from the field. ADAMA's diverse portfolio of existing active ingredients, coupled with its leading formulation capabilities and proprietary formulation technology platforms, uniquely position the company to develop high-quality, innovative and sustainable products, to address the many challenges farmers and customers face today. ADAMA serves customers in dozens of countries globally, with direct presence in all top 20 markets. For more information, visit us at www.ADAMA.com.
Abridged Adjusted Consolidated Financial Statements
The following abridged consolidated financial statements and notes have been prepared as described in Note 1 in this appendix. While prepared based on the principles of Chinese Accounting Standards (ASBE), they do not contain all of the information which either ASBE or IFRS would require for a complete set of financial statements,and should be read in conjunction with the consolidated financial statements of both ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock Exchanges, respectively.
Relevant income statement items contained in this release are also presented on an “Adjusted” basis, which exclude items that are of a one-time or non-cash/non-operational nature that do not impact the ongoing performance of the business, and reflect the way the Company's management and the Board of Directors view the performance of the Company internally. The Company believes that excluding the effects of these items from its operating results allows management and investors to effectively compare the true underlying financial performance of its business from period to period and against its global peers.
Abridged Consolidated Income Statement for the Third Quarter
Abridged Consolidated Income Statement for the First Nine Months of 2025
Abridged Consolidated Balance Sheet
Numbers may not sum due to rounding
Abridged Consolidated Cash Flow Statement for the Third Quarter of 2025
Abridged Consolidated Cash Flow Statement for the First Nine Months of 2025
Numbers may not sum due to rounding
Notes to Abridged Consolidated Financial Statements
Note 1: Basis of preparation
Basis of presentation and accounting policies: The abridged consolidated financial statements for the quarters ended September 30, 2025and 2024incorporate the financial statements of ADAMA Ltd. and of all of its subsidiaries (the “Company”), including Adama Agricultural Solutions Ltd. (“Solutions”) and its subsidiaries.
The Company has adopted the Accounting Standards for Business Enterprises (ASBE) issued by the Ministry of Finance (the “MoF”) and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the MoF (collectively referred to as “ASBE”).
The abridged consolidated financial statements contained in this release are presented in both Chinese Renminbi (RMB), as the Company's shares are traded on the Shenzhen Stock Exchange, as well as in United States dollars ($) as this is the major currency in which the Company's business is conducted. For the purposes of this release, a customary convenience translation has been used for the translation from RMB to US dollars, with Income Statement and Cash Flow items being translated using the quarterly average exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period.
The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated.
Note 2: Abridged Financial Statements
For ease of use, the financial statements shown in this release have been abridged as follows:
Abridged Consolidated Income Statement:
— “Gross profit” in this release is revenue less costs of goods sold, taxes and surcharges, inventory impairment and other idleness charges (in addition to those already included in costs of goods sold); part of the idleness charges is removed in the Adjusted financial statements
— “Other operating expenses” includes impairment losses (not including inventory impairment); gain (loss) from disposal of assets and non-operating income and expenses
— “Operating expenses” in this release differ from those in the formally reported financial statements in that certain transportation costs have been reclassified from COGS to Operating Expenses.
— “Financial expenses” includes net financing expenses and gains/losses from changes in fair value.
Abridged Consolidated Balance Sheet:
— “Other current assets, receivables and prepaid expenses” includes financial assets held for trading; financial assets in respect of derivatives; prepayments; other receivables; and other current assets
— “Fixed assets, net” includes fixed assets and construction in progress
— “Intangible assets, net” includes intangible assets and goodwill
— “Other non-current assets” includes other equity investments; long-term equity investments; long-term receivables; investment property; and other non-current assets
— “Loans and credit from banks and other lenders” includes short-term loans and non-current liabilities due within one year
— “Other current liabilities” includes financial liabilities in respect of derivatives; payables for employee benefits, taxes, interest, dividends and others; advances from customers and other current liabilities
— “Other long-term liabilities” includes long-term payables, provisions, deferred income and other non-current liabilities
Income Statement Adjustments
Notes:
1. Amortization of acquisition-related PPA and other acquisition related costs: Related mainly to the non-cash amortization of intangible assets created as part of the Purchase Price Allocation (PPA) on acquisitions, with no impact on the ongoing performance of the companies acquired, as well as other M&A-related costs.
2. Amortization of Transfer assets received and written-up due to 2017ChemChina-Syngenta transaction (non-cash):The proceeds from the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina, net of taxes and transaction expenses, were paid to Syngenta in return for the transfer of a portfolio of products in Europe of similar nature and economic value. Since the products acquired from Syngenta are of the same nature and with the same net economic value as those divested, and since in 2018 the Company adjusted for the one-time gain that it made on the divested products, the additional amortization charge incurred due to the written-up value of the acquired assets is also adjusted to present a consistent view of Divestment and Transfer transactions, which had no net impact on the underlying economic performance of the Company. These additional amortization charges will continue until 2032 but at a reducing rate, yet will still be at a meaningful level until 2028.
3. Cleanup and remediation costs for plants in Israel: a wholly-owned indirect subsidiary of the Company recorded remediation costs for its plants in Israel in 2025 and 2024.
4. & 5.ASBEs classifications COGS impact: according to the ASBE guidelines [IAS 37], certain items (specifically certain transportation costs) are classified under COGS.
6. Restructuring and advisory costs:The Company initiated its Fight Forward transformation plan in early 2024. Part of the plan includes restructuring its organizational structure, workforce and managerial processes, and as a result thereof, the Company recorded restructuring and advisory costs.
7. Other: Mainly attributable to accelerated depreciation associated with facilities upgrade.
8. Provisions such as legal claims, registration impairment and update of registration depreciation: Legal claims related to product liabilities was settled and incurred expenses in 2024. Registration impairment and update of registration depreciationis mainly related to the management's strategic decision to increase focus on products in line with the optimization of the Company's portfolio, and hence to focus on the quality of business.
9. Non-cash adjustment related to put options revaluation: expenses/incomedue to revaluation of put options attributed to minority stake in subsidiaries
10. Repurchase of debentures by a controlled subsidiary: As part of strengthening its debt structure, a subsidiary of the Company repurchased a significant part of its bond principal in the second quarter for the purpose of improving its long-term financing structure and efficiency. A loss was recorded due to the premium between the buyback price and its issuance price.
11. Arbitration decision related to a controlled subsidiary: An arbitration case related to a controlled subsidiary incurred a one-time income.
Exchange Rate Data for the Company's Principal Functional Currencies
Forward looking statement:
This press release published by ADAMA Ltd. or ADAMA Agricultural Solutions Ltd. (together the “Company”) is for marketing and information purposes only, and contains forward-looking statements which are based on Company's management's beliefs and assumptions and on information currently available to the Company's management. By this press release, the Company does not intend to give, and the press release does not constitute, professional or business advice or an offer or recommendation to perform any transaction in the Company's securities. The accuracy, completeness and/or adequacy of the content of this press release, as well as any estimation and/or assessment included in this press release, if at all, is not warranted or guaranteed and the Company disclaims any intention and/or obligation to comply with such content. The Company shall not be liable for any loss, claim, liability or damage of any kind resulting from your reliance on, or reference to, any detail, fact or opinion presented herein. The Company's assessments are based on the information available to the Company as of the date hereof, and may not be realized or be realized in a different manner than the Company estimates, inter alia, due to factors out of the Company's control, including the risk factors listed in the Company's annual reports and changes in the industry or potential operations of the Company's competitors. Any content contained herein shall not constitute or be construed as any regulatory, valuation, legal, tax, accounting and investment advice or any advice of any kind or any part of it, nor shall they constitute or be construed as any recommendation, solicitation, offer or commitment (or any part of it) to buy, sell, subscribe for or underwrite any securities, provide any credit or insurance or engage in any transactions. Before entering into any transactions, you shall ensure that you fully understand the potential risks and returns of such transactions. Before making such decisions, you shall consult the advisors you think necessary, including your accountant, investment advisor and legal and tax specialists. The Company and its affiliates, controlling persons, directors, officials, partners, employees, agents, representatives or their advisors shall not assume any responsibilities of any kind (including negligence or others) for the use of and reliance on such information by you or any person to whom such information are provided.
[1] Sources: AgbioInvestor Quarterly report (September 2025), peer quarterly financial results, internal sources
[2] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”.
[3] The number of shares used to calculate both basic and diluted earnings per share in both Q3 2025and 2024is 2,329.8 million shares.
[4] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”.
[5] The number of shares used to calculate both basic and diluted earnings per share in both 9M 2025and 2024is 2,329.8 million shares.
Logo -https://mma.prnewswire.com/media/799829/Adama_Agricultural_Solutions_Logo.jpg
https://edge.prnewswire.com/c/img/favicon.png?sn=LN09033&sd=2025-10-29
View original content:https://www.prnewswire.com/news-releases/adama-reports-third-quarter-and-first-nine-months-2025-results-302598367.html
SOURCE ADAMA Ltd.
https://rt.newswire.ca/rt.gif?NewsItemId=LN09033&Transmission_Id=202510290828PR_NEWS_USPR_____LN09033&DateId=20251029